Latest colorectal cancer News

Ultrasensitive liquid biopsy tech spots cancer earlier than standard methods
Promising Role Of Antidiabetic Drug In Cancer Control
Merck’s Innovative Oncology Pipeline of DNA Damage Response Inhibitors and Antibody-Drug Conjugates Poised to Advance Cancer Treatment
How Research In Common Cancers Is Helping Rare Cancers
Identifying the initial steps in colorectal cancer formation
Colon cancer rates are rising in young Americans, but insurance barriers are making screening harder
Exploring the effect of H2O2 eustress on individual cancer cells using hopping probe scanning ion conductance microscopy (HPICM)
Early onset bowel cancer on the rise
Gut microbiome: meet E coli – the infamous bacteria with an unfair reputation
FivepHusion announces ethics approval of Phase 1b trial of deflexifol as first-line treatment
Gut microbiome: meet Clostridium butyricum – the bacteria that helps keep us feeling our best
Silent cancers: here’s what you need to know when there are no obvious symptoms
Future Cancer Treatment And Fertility
Hamming it up: What’s the verdict on processed meat?
King Charles is having cancer treatment. What can he, and others with cancer, expect?
Deflexifol clinical data presented at ASCO Gastrointestinal Cancers Symposium
Lab-grown tumours predict treatment outcomes in landmark study
Global cancer burden growing, amidst mounting need for services
Key to young onset bowel cancer may be gut bacteria
Cracking the code: How what you eat might affect your cancer risk
Carina Biotech doses first patient in Phase 1/2a trial of LGR5-Targeted CAR-T cell therapy
Aggressive colon tumor may be vulnerable to cholesterol therapy
Even small amounts of physical activity could be valuable in late-stage lung cancer
Kate teaches ‘Art from heART’ to Mater patients
Wellcome Trust funds study of innate immune cells role in intestinal health and disease
Dr Ben Wylie research to develop kinder and less toxic treatments for cancer
Genetic switches in tumor development
UW research finds that mailing HPV test kits directly to patients increases cervical cancer screening rates
Updated guidelines on eligibility for colorectal cancer screening to reduce the impact of bowel cancer
Asbestos still risk to workers 20 years on from ban
Imfinzi plus chemotherapy approved in China as first immunotherapy regimen for patients with locally advanced or metastatic biliary tract cancer
45 is the new 50: Screening age drops due to rising rates of bowel cancer in under 50s
New research can help policymakers prioritise funding needs and allocate resource for cancer
Starpharma announces the presentation of DEP irinotecan combination data
Enhertu recommended for approval in the EU by CHMP for patients with HER2-mutant advanced non-small cell lung cancer
FivepHusion says first patient treated in paediatric brain cancer trial
Queensland cancer death rate reaches 25-year low this Daffodil Day
Chimeric reports positive in-vitro data for CHM 0301 next-generation cell platform
Engineering bacteria to detect cancer DNA
Genetically engineered bacteria can detect cancer cells in a world-first experiment
Is red meat bad for you? And does it make a difference if it’s a processed burger or a lean steak?
Screening age needs to be lowered to combat ‘epidemic’
Colorectal cancer organizations unite in screening age recommendations
AGA stands firm in CRC screening age recommendations
Allarity Therapeutics and FivepHusion announce collaboration for the development of Deflexifol with DRP Companion Diagnostics
Enhertu demonstrated clinically meaningful progression-free survival and overall survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Ludwig Chicago study develops an innovative approach to classify metastases in colorectal cancer patients
One month after UnitedHealthcare’s “advance notification” program began, confusion still reigns for America’s GI doctors